<abstract><p>Let $ \mathfrak{L} $ and $ A $ be Lie triple systems, and let $ \theta_A $ be a representation of $ \mathfrak{L} $ on $ A. $ We first construct the third-order cohomology classes by derivations of $ A $ and $ \mathfrak{L}, $ then obtain a Lie algebra $ G_{\theta_A} $ with a representation $ \Phi $ on $ H^3(\mathfrak{L}, A), $ where $ \theta_A $ is given by an abelian extension</p>
<p><disp-formula> <label/> <tex-math id="FE1"> \begin{document}$ 0\longrightarrow A\longrightarrow {\tilde {\mathfrak{L}}} \xrightarrow{\pi} \mathfrak{L}\longrightarrow 0. $\end{document} </tex-math></disp-formula></p>
<p>We study obstruction classes for extensibility of derivations of $ A $ and $ \mathfrak{L} $ to those of $ \tilde{\mathfrak{L}}. $ An application of $ \Phi $ is discussed.</p></abstract>
In this paper, we introduce the first and third cohomology groups on Leibniz triple systems, which can be applied to extension theory and 1-parameter formal deformation theory. Specifically, we investigate the central extension theory for Leibniz triple systems and show that there is a one-to-one correspondence between equivalent classes of central extensions of Leibniz triple systems and the third cohomology group. We study the T * -extension of a Leibniz triple system and we determined that every even-dimensional quadratic Leibniz triple system (L, B) is isomorphic to a T * -extension of a Leibniz triple system under a suitable condition. We also give a necessary and sufficient condition for a quadratic Leibniz triple system to admit a symplectic form. At last, we develop the 1-parameter formal deformation theory of Leibniz triple systems and prove that it is governed by the cohomology groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.